Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities
- PMID: 38494051
- PMCID: PMC11392652
- DOI: 10.1016/j.josat.2024.209352
Engagement, initiation, and retention in medication treatment for opioid use disorder among young adults: A narrative review of challenges and opportunities
Abstract
Introduction: Opioid Use Disorder (OUD) is a catastrophic public health problem for young adults (YAs) and their families. While medication for OUD (MOUD) is safe, effective, and recognized as the standard of care, its' uptake and success have been limited in YAs compared to older adults.
Methods: This narrative review summarizes the existing literature and highlights select studies regarding barriers to YA MOUD, potential explanations for those barriers, and strategies to overcome them.
Results: Barriers are prominent along the entire cascade of care, including: treatment engagement and entry, MOUD initiation, and MOUD retention. Hypothesized explanations for barriers include: developmental vulnerability, inadequate treatment system capacity, stigma against MOUD, among others. Interventions to address barriers include: promotion of family involvement, increasing provider capacity, integration of MOUD into primary care, assertive outreach, and others.
Conclusions: Integrating an adapted version of family coaching from the Community Reinforcement Approach and Family Training (CRAFT) and other models into YA MOUD treatment serves as an example of an emerging novel practice that holds promise for broadening the funnel of engagement in treatment and initiation of MOUD, and enhancing treatment outcomes. This and other developmentally-informed approaches should be evaluated as part of a high-priority clinical and research agenda for improving OUD treatment for YAs.
Keywords: Medication treatment; Opioid use disorder; Review; Young adults.
Copyright © 2024 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Fishman has been a consultant for Indivior, Alkermes, Drug Delivery LLC, Nirsum Labs. Dr. Marsch is affiliated with Square2 Systems Inc. and is a consultant for Boehringer Ingelheim and Click Therapeutics. These relationships are managed by her employer, Dartmouth College. Dr. Wenzel, Dr. Subramaniam, Dr. Levy, Dr. Borodovsky, Gauthier, McLeman, Fredyma, and Murray, have no financial or personal interests to declare. This manuscript reflects the views of the authors and may not reflect the opinions, views, and official policy or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. Dr. Subramaniam was substantially involved in this project, consistent with her role as Scientific Officer in the CTN grants. She has no financial or personal interests to declare.
Similar articles
-
Expert providers implement integrated and coordinated care in opioid use disorder treatment.Int J Drug Policy. 2024 Oct;132:104567. doi: 10.1016/j.drugpo.2024.104567. Epub 2024 Sep 5. Int J Drug Policy. 2024. PMID: 39241532
-
"I need as much support as I can get": A qualitative study of young adult perspectives on family involvement in treatment for opioid use disorder.J Subst Use Addict Treat. 2024 Dec;167:209512. doi: 10.1016/j.josat.2024.209512. Epub 2024 Sep 10. J Subst Use Addict Treat. 2024. PMID: 39265914
-
The cascade of care for opioid use disorder among youth in British Columbia, 2018.J Subst Abuse Treat. 2021 Nov;130:108404. doi: 10.1016/j.jsat.2021.108404. Epub 2021 Apr 18. J Subst Abuse Treat. 2021. PMID: 34118696 Review.
-
Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.Implement Res Pract. 2023 Feb 19;4:26334895231152808. doi: 10.1177/26334895231152808. eCollection 2023 Jan-Dec. Implement Res Pract. 2023. PMID: 37091535 Free PMC article.
-
Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.Epidemiol Rev. 2020 Jan 31;42(1):41-56. doi: 10.1093/epirev/mxaa001. Epidemiol Rev. 2020. PMID: 32239206 Free PMC article.
Cited by
-
Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, Update 2018-2023: Current Status, Best Practices, and Opportunities for Advancing the Science.J Clin Child Adolesc Psychol. 2025 Aug 4:1-25. doi: 10.1080/15374416.2025.2521855. Online ahead of print. J Clin Child Adolesc Psychol. 2025. PMID: 40758942
-
Engaging Patients in Substance Use Disorder Treatment by Offering Support They Are Willing to Accept.Focus (Am Psychiatr Publ). 2024 Oct;22(4):495-496. doi: 10.1176/appi.focus.20240032. Epub 2024 Oct 15. Focus (Am Psychiatr Publ). 2024. PMID: 39563871 No abstract available.
-
Exploring the Determinants of Treatment Completion Among Youth Who Received Medication-Assisted Treatment in the United States.Healthcare (Basel). 2025 Apr 2;13(7):798. doi: 10.3390/healthcare13070798. Healthcare (Basel). 2025. PMID: 40218094 Free PMC article.
References
-
- Ahrens K, Blackburn N, Aalsma M, Haggerty K, Kelleher K, Knight DK, Joseph E, Mulford C, Ryle T, & Tolou-Shams M (2023). Prevention of Opioid Use and Disorder Among Youth Involved in the Legal System: Innovation and Implementation of Four Studies Funded by the NIDA HEAL Initiative. Prevention Science, 24, 99–110. 10.1007/s11121-023-01566-6 - DOI - PMC - PubMed
-
- American Academy of Child and Adolescent Psychiatry. (2020). Opioid Use Disorder Treatment for Youth. Retrieved August 7, 2023 from https://www.aacap.org/AACAP/Policy_Statements/2020/Opioid_Use_Disorder_T...
-
- American Society of Addiction Medicine. (2019, December 18). The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. Retrieved August 7, 2023 from https://www.asam.org/quality-care/clinical-guidelines/national-practice-...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical